spacer
home > pmps > winter 2001 > progress towards child-resistant flexible packs for pharmaceuticals in the uk and the rest of european union
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Progress Towards Child-Resistant Flexible Packs for Pharmaceuticals in the UK and the Rest of European Union

Child-resistant (CR) packaging emerged in the US with the introduction of the Poisons Prevention Packaging Act of 1970. The 1975 Medicines (Child Safety) Regulations in the UK specified child-resistant packaging for some pharmaceuticals, initially solid dose children's aspirin and paracetamol and subsequently, adult versions of these drugs. The UK was the first European Union (EU) country to utilise CR packaging and the second country after the US.

Even today, standards for CR packaging and a legal duty to use the product exist only in the US, Canada, New Zealand, Australia, the UK, Germany and Italy.

The definitive test for child resistance is a protocol test where a sample of up to 200 children is used and asked to simply open the pack being tested. The sample is allowed two sessions; five minutes, then a silent demonstration, then a further five minutes. The pack fails (that is, it is not considered child-resistant) if 15 per cent of the sample open it prior to demonstration, or 20 per cent open it post-demonstration.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stephen Wilkins, Marketing Consultant and
Senior Partner at Stephen Wilkins Associates
Stephen Wilkins is a Marketing Consultant and Senior Partner of his own firm, Stephen Wilkins Associates. For more than 20 years he has run the firm, which specialises in industrial marketing communications. In 1993 he was appointed Marketing Consultant to Dragon Plastics Limited, a member of the CMA (USA's Closure Manufacturers Association), and he was appointed Secretary of the Child-Safe Packaging Group upon its formation in 1995.
As well as packaging, his research interests include above-the-line marketing communications and he has presented papers on both these subjects throughout the UK, Europe and the US. He graduated with a Masters in Business Administration from the University of Durham and is a Member of the Institute of Packaging in the UK and a Fellow of the Royal Society of Arts.

spacer
Stephen Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Surge of Indian biosimilars market forecast in 2019

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential’ in India throughout 2019 in the build-up to the 13th edition of CPhI India 2019, which will take place at the India Expo Centre in Delhi NCR.
More info >>

White Papers

High-tech Packaging for High-tech Medicine

West Pharmaceutical Services, Inc.

As more biologics and biosimilars come on to the global pharmaceutical market, they can and will present unique packaging and containment challenges. For materials that are sensitive to glass or that may require larger-dose volumes or custom configurations, cyclic olefin polymers may offer a solution. These novel materials for drug container closure systems can provide a needed alternative to traditional glass containment systems for advanced therapeutics.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement